CaiQZhaoXZhangX, et al. Ambulatory blood pressure characteristics are modulated by age and body weight in hypertensives: a cohort study of 35,367 patients. Angiology. 2026;77:762-771.
2.
HongSHChoiKM.Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci. 2020;21(2):494.
3.
da SilvaAAdo CarmoJMLiXWangZMoutonAJHallJE.Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671-682.
4.
LiBZhangQYangRHeYZhangH.Characteristics of inflammatory and normal endothelial exosomes on endothelial function and the development of hypertension. Inflammation. 2024;47(4):1156-1169.
5.
DinhQNDrummondGRSobeyCGChrissobolisS.Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960.
6.
QiHWenFYXieYY, et al. Associations between depressive, anxiety, stress symptoms and elevated blood pressure: findings from the CHCN-BTH cohort study and a two-sample Mendelian randomization analysis. J Affect Disord. 2023;341:176-184.
7.
BigalkeJADurocherJJGreenlundIMKeller-RossMCarterJR. Blood pressure and muscle sympathetic nerve activity are associated with trait anxiety in humans. Am J Physiol Heart Circ Physiol. 2023;324(4):H494-H503.
8.
IfeagwaziCMEgberiHEChukwuorjiJC.Emotional reactivity and blood pressure elevations: anxiety as a mediator. Psychol Health Med. 2018;23(5):585-592.
9.
HuangYSuYJiangYZhuM.Sex differences in the associations between blood pressure and anxiety and depression scores in a middle-aged and elderly population: the Irish Longitudinal Study on Ageing (TILDA). J Affect Disord. 2020;274:118-125.
10.
ZouYYeHXuZ, et al. Obesity, sarcopenia, sarcopenic obesity, and hypertension: mediating role of inflammation and insulin resistance. J Gerontol A Biol Sci Med Sci. 2025;80(3):glae284.
11.
PasdarYDarbandiMRezaeianSNajafiFHamzehBBagheriA.Association of obesity, sarcopenia, and sarcopenic obesity with hypertension in adults: a cross-sectional study from Ravansar, Iran during 2014-2017. Front Public Health. 2022;9:705055.
12.
ParkSHParkJHSongPS, et al. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens. 2013;7(6):420-425.
13.
GuptaDKLewisCEVaradyKA, et al. Effect of dietary sodium on blood pressure: a crossover trial. JAMA. 2023;330(23):2258-2266.
14.
HayesPFerraraAKeatingAMcKnightKO’ReganA.Physical activity and hypertension. Rev Cardiovasc Med. 2022;23(9):302.
